WASHINGTON – The Food and Drug Administration is proposing a new classification for a product that’s existed in a legal grey area for years, a win for proponents of dietary supplements, including members of the MAHA movement. The proposed rule would classify N-acetyl-L-cysteine, known as NAC and already widely sold over-the-counter, as the agency’s first “Dietary Ingredient Not Excluded from the Dietary Supplement Definition” — in essence, not not a supplement. The need for the legal backbending stems from the fact that the FDA previously approved NAC as a drug, and FDA regulations prohibit the agency from including approved drugs in the dietary supplement category. In 1963, the agency approved NAC to break up mucus in certain lung conditions, and in 1974 to treat acetaminophen overdose. STAT+ Exclusive Story Already have an account? Log in This article is exclusive to STAT+ subscribers Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+. Already have an account? Log in View All Plans To read the rest of this story subscribe to STAT+. Subscribe
STAT+: In a win for MAHA, FDA creates new regulatory category for the supplement NAC
Full Article
Original Source
Read the full article at Statnews →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.